CD­MO se­cures $31M Se­ries A to build out Ok­la­homa man­u­fac­tur­ing fa­cil­i­ty

Ok­la­homa may con­jure im­ages of cow­boys and the rolling plains of the Mid­west, but one CD­MO has wran­gled up funds, look­ing to turn the Soon­er State in­to a wider cen­ter for con­tract man­u­fac­tur­ing.

On Thurs­day, an­ti­body con­tract man­u­fac­tur­er Wheel­er Bio closed its Se­ries A round, pulling in $31 mil­lion. Lead­ing the round was Charles Riv­er Lab­o­ra­to­ries along with Echo, and Wheel­er al­so had par­tic­i­pa­tion from Al­loy Ther­a­peu­tics, Seag­ull Cap­i­tal, Plains Ven­ture Part­ners, Pine Ridge Ven­tures, ATUM and Float­ing Point Ad­vi­sors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER